Kudos to her for trying to tackle the arbitrary and inappropriate discretion allowed by the FAA in aeromedical evaluations. Oversight by an administrative agency requires discipline and some level of basic competence in the subject matter and there is troubling indication that the FAA is currently lacking both—basic competence as well as discipline—in many of the specialty fields of science that aviation encompasses.
But that alone won’t solve her problem. There is something fundamentally wrong with a medical device that initially administers such a high dose of treatment that the user is rendered impaired. Why is this allowed by the FDA? What is being done about it? If a testosterone patch created a similar overdose spike and deleterious effects for men there would he a howl of protest and a fix would be found pronto. Are the lives and careers of women of little to no concern to the FDA?